Christopher Hite – Biography
Last update: January 23, 2026Executive profile
Christopher was Chief Compliance Officer at Coolabah Capital Investments, and Chief Regulatory Officer at Nurp. Christopher Hite joined Royalty Pharma in 2025.
Christopher Hite is currentlyDirector at Kailera Therapeutics - View - Kailera Therapeutics org chart
Director at Vera Therapeutics - View - Vera Therapeutics org chart
Vice Chairman of the Board at Royalty Pharma - View - Royalty Pharma org chart
Create your alert
to follow the career of Christopher Hite.
More about Christopher Hite
Do you need to know more about Christopher Hite? More results.
Participate
Social media
- Christopher Hite on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Christopher Hite
The colleagues of Christopher Hite
Company Colleagues
- At Kailera Therapeutics, Christopher Hite has 29 colleagues including Ron Renaud (CEO), Martin Mackay (Director)…
- At Vera Therapeutics, Christopher Hite has 30 colleagues including Marshall Fordyce (CEO & Director), Maha Katabi (Director)…
- At Royalty Pharma, Christopher Hite has 36 colleagues including Pablo Legorreta (CEO & Chairman), Errol de Souza (Director)…
Industry Colleagues
- In the Healthcare industry, Christopher Hite has 54,619 colleagues in 3,494 companies located in 59 countries. 39,488 executive movements have been recorded in the last 12 months. Learn more about Healthcare.
Report an error
Update the org chart details of Christopher Hite.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Christopher Hite.
